Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults ...
There are two versions of the bill now; the original bill proposed capping the price of insulin for everybody who needs it.
Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...
A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...
Researchers decided to explore how the timing and intensity of workouts affect insulin sensitivity, with interesting results.
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
Researchers at the National Institute of Technology, Rourkela, said that, unlike traditional forecasting models that struggle ...
The study was conducted by cardiovascular researchers at the Karolinska Institute in Sweden and found that aspartame ...
Artificial sweeteners are everywhere, marketed as a healthier alternative to sugar, but new research suggests they may not be ...